Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20) for Recurrent Prostate Cancer After Surgery.

Clinical trial NCT07483658 · RECRUITING

Trial details

NCT number: NCT07483658
Sponsor: CHU de Quebec-Universite Laval
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Reccurent/Metastatic Solid Tumor Disease Prostate Cancer (Post Prostatectomy)Prostate Cancer Prostatic Neoplasms Neoplasm Recurrence, Local Biochemical Recurrence of Malignant Neoplasm of Prostate

Start date: 2026-05-13
Primary completion: 2029-12-01
Enrollment: 434

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.